Cheryl W. Grise - 14 Mar 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anna Nazarenko, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Mar 2022
Net transactions value
+$32,604
Form type
4
Filing time
16 Mar 2022, 16:37:53 UTC
Previous filing
05 Jan 2022
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $32,604 +504 +0.69% $64.69 73,193 14 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.